Tuesday, November 17, 2020

Will Life Return to Normal in the Next Year? These are 2 obstacles that need to be overcome!

 The announcement of a vaccine that has an order of more than 90% has raised hopes that the world can return to normal earlier than usual. According to the vaccine's creators, daily life is likely to return to normal at the beginning of the next winter.

Professor Ugur Sahin who is the co-founder and chief executive of BioNTech said that their vaccine could inhibit the transmission of Covid and ultimately lead to a large reduction in the number of infections.

Last week, Pfizer and BioNTech announced that preliminary analysis showed that their vaccine has more than 90% success in preventing a Covid-19 outbreak. As many as 43,500 people have taken part in the cation test.

The news has raised hopes that a vaccine could be rolled out before the end of the year although there are still obstacles to do so. The vaccine is expected to stop the spread of the Covid-19 epidemic which claimed more than 1.31 million lives worldwide.

Sahin added, if everything goes well, the vaccine will be distributed at the end of this year. The address is to transfer more than 300 million doses of vaccine so that April next year. He also added a number of vaccine companies that helped, so he predicts that in the next winter the world will return to normal.

In the same time, the Moderna company has announced that their Covid-19 vaccine recorded an order level of more than 94% to prevent the transmission of the related area. The order level exceeding 90% is amazing. Both Pfizer Inc. / BioNTech and Moderna Inc. has given hope to end this chapter.

However, the obstacles that need to be overcome are logistics and boarding problems. Vaccine manufacturers need to refrigerate the vaccine in a freezer. This has increased the cost of collecting and creating difficulties especially in countries with hot climates. However, the news of Moderna's vaccine order has made many parties relieved a little because the temperature requirements required by Moderna's vaccine are better than Pfizer's.

In the near future, Pfizer and Moderna vaccines must be diverted in a safe condition and not damaged.